If we want to have any hope of meeting the great challenges of our age – climate change, global health, inequalities, digital transformation – we must deploy and scale scientific and technological innovation at greater intensity than ever before.

“OUI is a catalyst for taking academic research beyond study and laboratory walls and into the outside world, driving both economic and societal impact.”

In Oxford, we understand this. Our response is translating our world-leading academic research into commercial, scalable innovations that have the capacity to respond to complex societal problems. The Oxford-AstraZeneca Vaccine deployed during an unprecedented pandemic is evidence of this.

In this – our first impact report – we set out our ability to push the boundaries of science, technology and social enterprise through company creation and through negotiating consulting partnerships with industry, government and beyond. Next year we plan to begin reviewing the impact of our licensing portfolio. Further metrics are in development as we seek to refine our approach to measuring impact.

As the technology transfer company of the University of Oxford, OUI provide support and expertise to enable researchers to harness commercial opportunities and begin their journey to deliver economic and societal impact. Epitomised by spinouts and startups such as Vaccitech, Mind Foundry, OrganOx and Wise Responder – you’ll discover just a few of our cutting-edge companies.

At OUI, we are fully aligned with both the UK intention to invest 2.4% of GDP in Research & Development by 2027, with £370 million for the UK’s most promising emerging technologies, and the UN Sustainable Development Goals (SDGs).

Indeed, this report maps our companies’ commitment to help deliver the SDGs and how we are able to support this through working closely with our partners across the University, the investor community and industry.

In Oxford, we are driving the UK’s knowledge economy and helping to strengthen our nation’s position on the global stage of science, technology and enterprise.

I hope you will join us in celebrating the achievements we report here. But if we want to have a hope of responding to the urgency of the great global challenges of today, we need to work together at pace and scale to develop new opportunities to deliver more impact today and for future generations. I look forward to working with you to do just that.

 

At OUI we are fully aligned with both the UK intention to invest 2.4% of GDP in Research & Development by 2027, with £370 million for the UK’s most promising emerging technologies, and the UN Sustainable Development Goals (SDGs).